Literature DB >> 26654692

Neonatal Fc Receptor Binding Tolerance toward the Covalent Conjugation of Payloads to Cysteine 34 of Human Albumin Variants.

Steffan S Petersen1,2, Eva Kläning1,2, Morten F Ebbesen1,2, Birgitte Andersen3, Jason Cameron4, Esben S Sørensen2, Kenneth A Howard1,2.   

Abstract

The long circulatory half-life of albumin facilitated by the interaction with the cellular recycling neonatal Fc receptor (FcRn) is utilized for drug half-life extension. FcRn engagement effects following covalent attachment of cargo to cysteine 34, however, have not been investigated. Poly(ethylene glycol) polymers were used to study the influence of cargo molecular weight on human FcRn engagement of recombinant wild type (WT) albumin and an albumin variant engineered for increased FcRn binding. Decreased affinity was observed for all conjugates; however, the engineered albumin maintained an affinity above that of unmodified wild type albumin that promotes it as an attractive drug delivery platform.

Entities:  

Keywords:  albumin; biolayer interferometry; covalent conjugation; cysteine 34; neonatal Fc receptor (FcRn); poly(ethylene glycol)

Mesh:

Substances:

Year:  2015        PMID: 26654692     DOI: 10.1021/acs.molpharmaceut.5b00605

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  4 in total

1.  Drug-free albumin-triggered sensitization of cancer cells to anticancer drugs.

Authors:  Lian Li; Jiyuan Yang; Sirima Soodvilai; Jiawei Wang; Praneet Opanasopit; Jindřich Kopeček
Journal:  J Control Release       Date:  2018-11-19       Impact factor: 9.776

2.  A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation.

Authors:  Karen Kræmmer Schelde; Karl Nicholls; Frederik Dagnæs-Hansen; Karen Bunting; Helen Rawsthorne; Birgitte Andersen; Christopher J A Finnis; Miranda Williamson; Jason Cameron; Kenneth A Howard
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

3.  Human serum albumin presents isoform variants with altered neonatal Fc receptor interactions.

Authors:  Yann Leblanc; Marie Berger; Alexander Seifert; Nicolas Bihoreau; Guillaume Chevreux
Journal:  Protein Sci       Date:  2019-11       Impact factor: 6.725

4.  An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications.

Authors:  Matthias Kuhlmann; Jonas B R Hamming; Anders Voldum; Georgia Tsakiridou; Maja T Larsen; Julie S Schmøkel; Emil Sohn; Konrad Bienk; David Schaffert; Esben S Sørensen; Jesper Wengel; Daniel M Dupont; Kenneth A Howard
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.